MedTrace Logo

Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program

NCT00498147 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1213

Last updated 2009-10-06

No results posted yet for this study

Summary

The primary objective of this study is to identify whether cardiovascular complication rates are lower in patients who participate in managed diabetes care, in comparison to provincial and national rates. This study will involve an electronic medical record (EMR) chart audit, augmented by a manual review of hospital and other pertinent medical records, as necessary.

Conditions

  • Disease Management
  • Diabetes Complications
  • Diabetic Vascular Complications
  • Diabetic Neuropathy
  • Diabetic Nephropathy
  • Diabetic Retinopathy

Interventions

OTHER

ADEC Program

Interventions (managed diabetes care) employed by the ADEC Program include: diabetes education, nutrition care, individual and group counseling sessions, foot care, and insulin and oral diabetes medication adjustments with a signed medical directive. ADEC Diabetes Educators (Registered Dietitians and Registered Nurses) will use adult education principles throughout the education process and promote self-care by encouraging responsibility and promoting a positive attitude towards acceptance of diabetes. All patients will be encouraged to self-monitor their blood glucose at home. Team member collaboration and with other agencies to promote a total client care approach to diabetes management will be employed.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Group Health Centre

    lead OTHER

Principal Investigators

  • Silvana Spadafora, MD FRCPC · The Group Health Centre

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2010-03-31
Completion
2010-07-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00498147 on ClinicalTrials.gov